Generic and Biosimilar Medicines, Central to Patient Health and Global Healthcare Policies (September 2022)
Experts and leaders from the local and global generic and biosimilar medicines industry, Government and UN agencies, patient organizations, academia and other stakeholders are meeting from 7 to 9 September in Kuala Lumpur, Malaysia to discuss key topics affecting worldwide patient access to affordable medicines, such as...
